Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is a prominent entity in the pharmaceuticals industry, primarily focused on research, development, and manufacturing of traditional Chinese medicines and modern pharmaceuticals. As one of China's leading pharmaceutical companies, it maintains a robust portfolio that includes herbal medicine, chemical pharmaceuticals, and biotechnological products, catering to both domestic and international markets. The company's products are extensively used in therapeutic areas such as cardiovascular, respiratory, and metabolic health, reflecting its influence across various health-related sectors. Established in one of China's economic growth hubs, Tianjin, the corporation plays a crucial role in advancing medical health solutions aligned with traditional and contemporary scientific approaches. Its strategic importance in the pharmaceutical market is significant due to its comprehensive approach in addressing the health needs through innovation and adherence to China's rich medicinal heritage, thus impacting community health at large.
Markedsdata leveret af TwelveData og Morningstar